IWP's Underlying Holdings Could Mean 11% Gain Potential
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 22 2025
0mins
Should l Buy VEEV?
Source: NASDAQ.COM
ETF Analysis: The iShares Russell Mid-Cap Growth ETF (IWP) has an implied analyst target price of $144.41, indicating a potential upside of 10.59% from its recent trading price of $130.58.
Stock Performance Insights: Notable underlying holdings such as Ionis Pharmaceuticals, Veeva Systems, and Ares Management show significant upside potential based on analyst targets, raising questions about the validity of these projections amidst market conditions.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VEEV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VEEV
Wall Street analysts forecast VEEV stock price to rise
23 Analyst Rating
16 Buy
6 Hold
1 Sell
Moderate Buy
Current: 185.910
Low
222.00
Averages
317.10
High
380.00
Current: 185.910
Low
222.00
Averages
317.10
High
380.00
About VEEV
Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. It offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and the strategic business functions from research and development (R&D) through commercialization. Its four product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes, and partners across content management, training, quality management, assurance, and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Veeva Data Cloud is a data platform comprised of connected reference data, deep data, and transaction data.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

- Strong Performance: Veeva Systems reported total revenue of $836 million and non-GAAP operating income of $366 million for Q4 fiscal 2026, exceeding company guidance and reflecting robust market demand and execution capabilities.
- Deepening Strategic Partnerships: CEO Peter Gassner highlighted that Veeva's strategic partnerships in life sciences have strengthened, with total revenue reaching $3.195 billion for fiscal 2026, surpassing the $3 billion revenue run-rate goal, underscoring the company's leadership in the industry.
- Accelerated Customer Transition: The number of customers migrating to the Vault CRM system increased from 125 to nearly 140, indicating strong acceptance of the new system and providing excellent cross-sell opportunities that are expected to further drive revenue growth.
- AI Application Potential: While AI is not yet a major driver for core system decisions, the extreme interest from customers in AI integration indicates that Veeva will continue to focus on AI capabilities in future product development to meet market demands for efficient solutions.
See More
- Mixed Midcap Performance: In Q4 2025, midcap stocks showed mixed results, with the Russell Midcap Growth Index declining by 3.70% while the Russell Midcap Value Index rose by 1.41%, indicating varying investor responses to different styles that could influence asset allocation decisions.
- Sector Return Disparities: Within the growth index, the materials sector led with a 17.51% absolute return, yet its limited weight in the index restricted its overall contribution, highlighting the importance of sector selection in investment strategies.
- Veeva Systems' Market Position: Veeva Systems Inc. (NYSE:VEEV) was highlighted in the investor letter despite a 15.47% decline over the past 52 weeks; the company is addressing competitive pressures by launching AI products, showcasing its deep expertise in life sciences and potential for market share recovery.
- Future Market Outlook: Carillon Eagle Fund expresses optimism for equity markets in 2026, identifying potential opportunities in Cyclicals, Healthcare, Information Technology, Financials, and Consumer Spending sectors, which may provide new growth avenues for investors.
See More
- Strong Financial Performance: Veeva Systems reported fourth-quarter revenue of $836 million, a 16% year-over-year increase, surpassing the market expectation of $810.6 million, indicating robust growth potential in the life sciences sector.
- Earnings Beat Expectations: The company posted earnings per share of $2.06, exceeding the analyst consensus of $1.93, reflecting ongoing improvements in profitability and boosting investor confidence.
- Optimistic Guidance: Veeva's first-quarter revenue guidance ranges from $855 million to $858 million, above the analyst forecast of $847.2 million, demonstrating the company's confidence in future performance.
- Positive Stock Reaction: Following the earnings announcement, Veeva's stock surged 11.3% in pre-market trading to $209.81, indicating market recognition of its growth potential.
See More
- Stock Market Trends: Stock futures were modestly lower on Thursday, indicating a cautious sentiment among investors.
- Investor Sentiment: Investors are trying to interpret mixed messages regarding ongoing peace talks between the U.S. and Iran.
See More
- Futures Market Movement: U.S. stock futures fell on Thursday, with major benchmark indices showing declines, reflecting market caution ahead of upcoming economic data, particularly following a positive close on Wednesday that may influence investor sentiment.
- Bond Yield Trends: The 10-year Treasury bond yielded 3.11%, while the two-year bond stood at 3.56%, indicating market expectations regarding interest rate policies; the CME Group's FedWatch tool shows a 97.3% likelihood of the Federal Reserve keeping rates unchanged in March.
- Stock Highlights: Broadcom Inc. (NASDAQ:AVGO) surged 6.66% in premarket trading after reporting better-than-expected financial results for Q1 FY2026, demonstrating a strong long-term trend despite a weaker price trend in the short term.
- Analyst Insights: BlackRock maintains a cautiously optimistic outlook on the U.S. economy and stock market, driven by “mega forces” like artificial intelligence, suggesting a scenario-based approach to navigate future uncertainties despite recent inflation concerns and volatility in the S&P 500.
See More
- Strong Financials: Veeva Systems reported Q4 revenue of $836 million, a 16% year-over-year increase, surpassing the market expectation of $810.6 million, indicating robust growth potential in the life sciences sector.
- Earnings Beat: The company posted earnings per share of $2.06, exceeding the consensus estimate of $1.93, reflecting ongoing improvements in profitability and boosting investor confidence.
- Stock Surge: Veeva Systems shares jumped 11.3% in pre-market trading to $209.81, indicating a positive market reaction to its financial performance and future outlook.
- Optimistic Guidance: The company raised its FY27 guidance above market expectations, further solidifying its leadership position in the industry and laying a strong foundation for future growth.
See More








